Canada Life’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Canada Life’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-31,778	Closed	-$570K	–	2746
2017 Q4	$570K	Sell	31,778 -4,000	-11%	-$49.2K	﹤0.01%	1696
2017 Q3	$411K	Hold	35,778	–	–	﹤0.01%	1772
2017 Q2	$374K	Hold	35,778	–	–	﹤0.01%	1769
2017 Q1	$392K	Buy	35,778 +32,203	+901%	+$374K	﹤0.01%	1766
2016 Q4	$49K	Hold	3,575	–	–	﹤0.01%	2330
2016 Q3	$44K	Hold	3,575	–	–	﹤0.01%	2355
2016 Q2	$39K	Hold	3,575	–	–	﹤0.01%	2365
2016 Q1	$39K	Hold	3,575	–	–	﹤0.01%	2211
2015 Q4	$62K	Hold	3,575	–	–	﹤0.01%	2054
2015 Q3	$71K	Buy	+3,575	New	+$82K	﹤0.01%	1927

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Canada Life's SCMP Position: Q1 2018 in Review

Canada Life sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 31,778 shares — an estimated $570K sold.

Canada Life first reported a position in SCMP in Q3 2015 and held it in 10 quarters. The position peaked at $570K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Canada Life reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Canada Life sold 31,778 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $570K.
Canada Life first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 10 quarters.
Canada Life's Sucampo Pharmaceuticals, Inc. position peaked at $570K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Canada Life's 13F filing for Q1 2018, filed 10 May 2018.